Literature DB >> 20214890

A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor.

Yoko Yashiroda1, Reika Okamoto, Kaori Hatsugai, Yasushi Takemoto, Naoki Goshima, Tamio Saito, Makiko Hamamoto, Yoshikazu Sugimoto, Hiroyuki Osada, Hiroyuki Seimiya, Minoru Yoshida.   

Abstract

The telomere-associated protein tankyrase 1 is a poly(ADP-ribose) polymerase and is considered to be a promising target for cancer therapy, especially for BRCA-associated cancers. However, an efficient assay system for inhibitor screening has not been established, mainly due to the difficulty of efficient preparation of the enzyme and its substrate. Here, we report a cell-based assay system for detecting inhibitory activity against tankyrase 1. We found that overexpression of the human tankyrase 1 gene causes a growth defect in the fission yeast Schizosaccharomyces pombe. Chemicals that restore the growth defect phenotype can be identified as potential tankyrase 1 inhibitors. We performed a high-throughput screen using this system, and identified flavone as a compound that restores the growth of yeast cells overexpressing tankyrase 1. Indeed, flavone inhibited poly(ADP-ribosyl)ation of proteins caused by overexpression of tankyrase 1 in yeast cells. This system allows rapid identification of inhibitory activity against tankyrase 1 and is amenable to high-throughput screening using robotics. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214890     DOI: 10.1016/j.bbrc.2010.03.021

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  A Novel Class of HIV-1 Inhibitors Targeting the Vpr-Induced G2-Arrest in Macrophages by New Yeast- and Cell-Based High-Throughput Screening.

Authors:  Hirotaka Sato; Tomoyuki Murakami; Ryosuke Matsuura; Masako Abe; Seiji Matsuoka; Yoko Yashiroda; Minoru Yoshida; Hirofumi Akari; Yosuke Nagasawa; Masami Takei; Yoko Aida
Journal:  Viruses       Date:  2022-06-16       Impact factor: 5.818

2.  Anti-cancer drug discovery: update and comparisons in yeast, Drosophila, and zebrafish.

Authors:  Guangxun Gao; Liang Chen; Chuanshu Huang
Journal:  Curr Mol Pharmacol       Date:  2014       Impact factor: 3.339

3.  Identification through high-throughput screening of 4'-methoxyflavone and 3',4'-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos.

Authors:  A A Fatokun; J O Liu; V L Dawson; T M Dawson
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 4.  Structural Implications for Selective Targeting of PARPs.

Authors:  Jamin D Steffen; Jonathan R Brody; Roger S Armen; John M Pascal
Journal:  Front Oncol       Date:  2013-12-20       Impact factor: 6.244

5.  mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.

Authors:  Tetsuo Mashima; Yoko Taneda; Myung-Kyu Jang; Anna Mizutani; Yukiko Muramatsu; Haruka Yoshida; Ayana Sato; Noritaka Tanaka; Yoshikazu Sugimoto; Hiroyuki Seimiya
Journal:  Oncotarget       Date:  2017-07-18

6.  RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.

Authors:  Anna Mizutani; Yoko Yashiroda; Yukiko Muramatsu; Haruka Yoshida; Tsubasa Chikada; Takeshi Tsumura; Masayuki Okue; Fumiyuki Shirai; Takehiro Fukami; Minoru Yoshida; Hiroyuki Seimiya
Journal:  Cancer Sci       Date:  2018-10-20       Impact factor: 6.716

7.  3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition.

Authors:  Sarfaraz Alam; Feroz Khan
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

Review 8.  Tankyrase-targeted therapeutics: expanding opportunities in the PARP family.

Authors:  Jenna L Riffell; Christopher J Lord; Alan Ashworth
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

9.  Panspecies small-molecule disruptors of heterochromatin-mediated transcriptional gene silencing.

Authors:  Emilie Castonguay; Sharon A White; Alexander Kagansky; Daniel J St-Cyr; Araceli G Castillo; Christiane Brugger; Rachel White; Carolina Bonilla; Michaela Spitzer; William C Earnshaw; Thomas Schalch; Karl Ekwall; Mike Tyers; Robin C Allshire
Journal:  Mol Cell Biol       Date:  2014-12-08       Impact factor: 4.272

Review 10.  Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.

Authors:  Laura Mariotti; Katie Pollock; Sebastian Guettler
Journal:  Br J Pharmacol       Date:  2017-11-05       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.